Effects of the non-peptide B2 antagonist FR173657 on kinin-induced smooth muscle contraction and relaxation, vasoconstriction and prostaglandin release

British Journal of Pharmacology

Volumn 121, Issue 3, 1997, Pages 469-476

  Griesbacher, Thomas ^c   Sametz, Wolfgang ^a   Legat, Franz J ^b   Diethart, Sabine ^a   Hammer, Susanne ^a   Juan, Heinz ^a  

^a MEDICAL UNIVERSITY OF GRAZ   (Austria)

^b Universitatsklinik fur Dermatologie und Venerologie   (Austria)

^c UNIVERSITY OF GRAZ   (Austria)

Author keywords

Bradykinin antagonists; Bradykinin receptors; FR173657; Prostaglandin release; Smooth muscle contraction; Smooth muscle relaxation; Vasoconstriction

Indexed keywords

3 (6 ACETAMIDO 3 PYRIDYL) N [N [2,4 DICHLORO 3 [(2 METHYL 8 QUINOLINYL)OXYMETHYL]PHENYL] N METHYLAMINOCARBONYLMETHYL]ACRYLAMIDE; 3 (6 ACETAMIDO 3 PYRIDYL) N [N [2,4 DICHLORO 3 [(2 METHYL 8 QUINOOLINYL)OXYMETHYL]PHENYL] N METHYLAMINOCARBONYLMETHYL]ACRYLAMIDE; ACETYLCHOLINE; ANGIOTENSIN; BRADYKININ; BRADYKININ B1 RECEPTOR; BRADYKININ B2 RECEPTOR; BRADYKININ B2 RECEPTOR ANTAGONIST; BRADYKININ RECEPTOR; CERULETIDE; HISTAMINE; ISOPRENALINE; KININ; NORADRENALIN; PROSTACYCLIN; PROSTAGLANDIN; PROSTAGLANDIN E2; SEROTONIN; SUBSTANCE P; UNCLASSIFIED DRUG;

ANIMAL TISSUE; ARTICLE; CONCENTRATION RESPONSE; CONTROLLED STUDY; DOSE TIME EFFECT RELATION; DRUG POTENCY; DUODENUM; EAR; FEMALE; GUINEA PIG; INTESTINE MUSCLE; INTRAARTERIAL DRUG ADMINISTRATION; MALE; MYOMETRIUM; NONHUMAN; PRIORITY JOURNAL; PROSTAGLANDIN RELEASE; RABBIT; RAT; RECEPTOR AFFINITY; SMOOTH MUSCLE CONTRACTION; SMOOTH MUSCLE RELAXATION; TRACHEA MUSCLE; VASCULAR SMOOTH MUSCLE; VASOCONSTRICTION;

ANIMALS; DUODENUM; FEMALE; GUINEA PIGS; ILEUM; MALE; MUSCLE CONTRACTION; MUSCLE, SMOOTH; PROSTAGLANDINS; QUINOLINES; RABBITS; RATS; RATS, SPRAGUE-DAWLEY; RECEPTOR, BRADYKININ B2; RECEPTORS, BRADYKININ; TRACHEA; UTERINE CONTRACTION; VASOCONSTRICTION;

EID: 0030913686     PISSN: 00071188     EISSN: None     Source Type: Journal    
DOI: 10.1038/sj.bjp.0701159     Document Type: Article

References (34)

1. ARUNLAKSHANA, O. & SCHILD, H.O. (1959). Some quantitative uses of drug antagonism. Br. J. Pharmacol. Chemother., 14, 48-58.
2. BIRCH, P.J., FERNANDEZ, L., HARRISON, S.M. & WILKINSON, A. (1991). Pharmacological characterization of the receptors mediating the contractile response to bradykinin in the guinea-pig ileum and rat uterus. Br. J. Pharmacol., 102, 170P.
3. 3 receptor. Mol. Pharmacol., 36, 1-8.
4. 3 receptor. Br. J. Pharmacol., 112, 461-464.
5. 2 receptor antagonist, in vitro and in vivo. J. Pharmacol. Exp. Ther., 273, 1071-1077.
6. 3 receptors in the guinea-pig trachea and are blocked by HOE 140. Br. J. Pharmacol., 105, 293-296.
7. GEIGY. (1980). Scientific Tables Geigy (Statistics). 8th ed. Basel: Ciba-Geigy.
8. GRIESBACHER, T. (1992). Kinin-induced relaxations of the rat duodenum. Naunyn-Schmiedeberg's Arch. Pharmacol., 346, 102-107.
9. 2 antagonist, on kinin-induced hypotension, visceral and peripheral oedema formation and bronchoconstriction. Br. J. Pharmacol., 120, 933-939.
10. GRIESBACHER, T. & LEMBECK, F. (1992). Analysis of the antagonistic actions of HOE 140 and other novel bradykinin analogues on the guinea-pigileum. Eur. J. Pharmacol., 211, 393-398.
11. GRIESBACHER, T., LEMBECK, F. & SARIA, A. (1989). Effects of the bradykinin antagonist B4310 on smooth muscles and blood pressure in the rat, and its enzymatic degradation. Br. J. Pharmacol., 96, 531-538.
12. GUTH, P.S., BOBBIN, R., CANO, G. & AMARO, J. (1966). Venoconstriction induced by bradykinin in the rabbit ear. In Hypotensive Peptides. ed. Erdös, E.G., Back, N. & Sicuteri, F. pp. 396-406. Berlin, Heidelberg, New York: Springer.
13. HALL, J.M. (1992). Bradykinin receptors: pharmacological properties and biological roles. Pharmacol. Ther., 56, 131-190.
14. HOCK, F.J., WIRTH, K., ALBUS, U., LINZ, W., GERHARDS, H.J., WIEMER, G., HENKE, S., BREIPOHL, G., KÖNIG, W., KNOLLE, J. & SCHÖLKENS, B.A. (1991). Hoe 140 a new potent and long acting bradykinin-antagonist: in vitro studies. Br. J. Pharmacol., 102, 769-773.
15. 2 antagonist, in vitro and in vivo studies. International Symposium 'Peptide Receptors', Montréal, Canada, 28 July-1 August 1996.
16. JUAN, H. (1978). Prostaglandins as modulators of pain. Gen. Pharmacol., 9, 403-409.
17. 14C)-arachidonic acid stimulated by bradykinin. Adv. Exp. Med. Biol., 156A, 519-526.
18. JUAN, H. & SAMETZ, W. (1986). Vasoconstriction induced by noradrenaline and angiotensin II is antagonized by eicosapentaenoic acid independent of formation of trienoic eicosanoids. Naunyn-Schmiedeberg's Arch. Pharmacol., 332, 288-292.
19. KENAKIN, T. (1993). Pharmacologic Analysis of Drug-Receptor Interaction, 2nd ed. New York: Raven Press.
20. LEMBECK, F., GRIESBACHER, T, ECKHARDT, M., HENKE, S., BREIPOHL, G. & KNOLLE, J. (1991). New, long-acting, potent bradykinin antagonists. Br. J. Pharmacol., 102, 297-304.
21. 2 receptor antagonist. Hoe 140, in the rat uterus. Eur. J. Pharmacol., 235, 183-188.
22. 3 receptors in vitro. Br. J. Pharmacol., 102, 171P.
23. 2 receptor in the guinea-pig. Br. J. Pharmacol., 116, 2106-2116.
24. REGOLI, D. & BARABÉ, J. (1980). Pharmacology of bradykinin and related kinins. Pharmacol. Rev., 32, 1-46.
25. REGOLI, D., JUKIC, D., GOBEIL, F. & RHALEB, N.-E. (1993). Receptors for bradykinin and related kinins: a critical review. Can. J. Physiol. Pharmacol., 71, 556-567.
26. 8]bradykinin). Eur. J. Pharmacol., 210, 115-120.
27. 2 receptor. J. Med. Chem., 36, 2583-2584.
28. 2 receptor antagonist. Proc. Natl. Acad. Sci. U.S.A., 91, 4693-4697.
29. 2 receptor antagonist, on guinea-pig trachea. Br. J. Pharmacol., 115, 1127-1128.
30. STEWART, J.M. & VAVREK, R.J. (1986). Bradykinin competitive antagonists for classical kinin systems. Adv. Exp. Med. Biol., 198, 537-542.
31. WIRTH, K.J., HEITSCH, H. & SCHÖLKENS, B.A. (1995). Kinin receptor antagonists: unique probes in basic and clinical research. Can. J. Physiol. Pharmacol., 73, 797-804.
32. WIRTH, K., HOCK, F.J., ALBUS, U., LINZ, W., ALPERMANN, H.G., ANAGNOSTOPOULOS, H., HENKE, S., BREIPOHL, G., KÖNIG, W., KNOLLE, J. & SCHÖLKENS, B.A. (1991). Hoe 140 a new potent and long acting bradykinin-antagonist: in vivo studies. Br. J. Pharmacol., 102, 774-777.
33. 9-bradykinin in endothelial cells. Eur. J. Pharmacol., 288, R1-R2.
34. ZAR, J.H. (1984). Biostatistical Analysis. 2nd ed. Englewood Cliffs, N.J.: Prentice-Hall.